Riskpilot← Back to searchSign inGet full accessCONDOVITA AS
ASActiveOrg 998054761Finnhaugveien 6A, 0760 OsloRental and operating of own or leased real estate · NACE 6820Est. 20120 employees
Revenue 2024
NOK 0
EBITDA margin
—
+25% vs 2023
Equity ratio
64.3%
Financial strength
Net profit 2024
NOK -969K
-149% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -1,2M | +25% |
| Net profit | NOK -969K | -149% |
| Total assets | NOK 4,4M | -15% |
| Equity | NOK 2,8M | -25% |
| Employees | 0 | — |
Legal name
CONDOVITA AS
Org number
998054761
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
5. mars 2012
Share capital
NOK 124 970
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Utvikle, oppføre, eie og drive helseeiendommer og boligbygg med tilrettelagte servicetjenester, primært innenfor segmentet helsebygg, sykehjem, omsorgs- og seniorboliger. Selskapet skal utøve sin virksomhet alene eller i samhandling med lokale eller sentrale offentlige myndigheter, ideelle organisasjoner eller private aktører. Selskapet kan gjennom kapitalinnskudd delta i andre virksomheter tilknyttet eiendoms- og/eller helse og samfunnsmessige formål for øvrig.
Address
Finnhaugveien 6A, 0760 Oslo
Phone
+4792493314
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 047 | 9 963 | 24 988 | 117 | 0 |
| Staff expenses | −3 625 | −3 869 | −6 849 | −536 | −298 |
| EBITDA | −5 695 | 1 029 | −19 211 | −1 605 | −1 203 |
| Depreciation & amort. | −13 | −19 | −11 | −7 | −1 |
| EBIT | −5 709 | 1 010 | −19 222 | −1 611 | −1 204 |
| Net financials | 454 | −1 062 | −19 388 | 3 588 | 235 |
| Profit before tax | −5 255 | −51 | −38 610 | 1 977 | −969 |
| Tax | −1 107 | 2 437 | −0 | −0 | −0 |
| Net profit | −4 148 | −2 488 | −38 610 | 1 977 | −969 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 61 958 | 56 890 | 4 463 | 5 166 | 4 413 |
| Equity | 57 998 | 55 510 | 1 900 | 3 808 | 2 838 |
| Long-term debt | 2 000 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 960 | 1 381 | 2 563 | 1 358 | 1 074 |
| Total debt | 3 960 | 1 381 | 2 563 | 1 358 | 1 074 |
EBITDA margin
-120312400.0%
This company
15.8%
Market median
-761470986% vs market
20202024
Equity ratio
64.3%
This company
38.2%
Market median
+68% vs market
20202024
Return on equity
-34.2%
This company
18.4%
Market median
-286% vs market
20202024
Net profit margin
-96945400.0%
This company
8.1%
Market median
-1196856890% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FB Deputy Member | Deputy Member | 2023 |
| Former (1) | ||
TB Chief Executive Officer | Chief Executive Officer | 2016 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 48.77% | 48.77% | 2024 | |
| Company | 7.75% | 7.75% | 2024 | |
| Individual | 5.78% | 5.78% | 2024 | |
| Company | 3.6% | 3.6% | 2024 | |
| Company | 3.59% | 3.59% | 2024 | |
| Company | 3.2% | 3.2% | 2024 | |
| Company | 3.11% | 3.11% | 2024 | |
| Company | 3.08% | 3.08% | 2024 | |
| Company | 2.55% | 2.55% | 2024 | |
| Company | 2.31% | 2.31% | 2024 | |
| Company | 2.24% | 2.24% | 2024 | |
| Company | 2% | 2% | 2024 | |
| Company | 1.68% | 1.68% | 2024 | |
| Company | 1.67% | 1.67% | 2024 | |
| Company | 1.65% | 1.65% | 2024 | |
| Individual | 1.57% | 1.57% | 2024 | |
| Company | 1.44% | 1.44% | 2024 | |
| Company | 1.12% | 1.12% | 2024 | |
| Company | 1.12% | 1.12% | 2024 | |
| Company | 1.12% | 1.12% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CONDOVITA AS 
NORSKE HELSEHUS ASBoard members of CONDOVITA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Berndt Daniel Lundgren | Deputy Member | 0 companies |
| Tore Borthen | Chief Executive Officer | 0 companies |
| Endre Storløkken | Chairman | 0 companies |
| Geir Odd Målsnes | Chairman | 0 companies |
| Hans Erik Lie | Board of Directors | 0 companies |